- $116.32m
- $79.42m
- $51.37m
- 89
- 91
- 18
- 73
Annual income statement for AMREP, fiscal year end - April 30th, USD millions except per share, conversion factor applied.
2020 April 30th | 2021 April 30th | C2022 April 30th | 2023 April 30th | 2024 April 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 18.8 | 40.1 | 58.9 | 48.7 | 51.4 |
| Cost of Revenue | |||||
| Gross Profit | 3.02 | 14.5 | 26.7 | 18.9 | 14.5 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 26.7 | 30.7 | 37.6 | 42.8 | 43.8 |
| Operating Profit | -7.96 | 9.35 | 21.3 | 5.83 | 7.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -7.63 | 10 | 21.6 | 7.64 | 8.43 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -5.9 | 7.39 | 15.9 | 21.8 | 6.69 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -5.9 | 7.39 | 15.9 | 21.8 | 6.69 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -5.9 | 7.39 | 15.9 | 21.8 | 6.69 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.088 | 0.923 | 2.2 | 5.04 | 1.25 |